"Pioglitazone reduces serum ketone bodies in sodium‐glucose cotransporter‐2 inhibitor‐treated non‐obese type 2 diabetes: A single‐centre, randomized, crossover trial"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Pioglitazone reduces serum ketone bodies in sodium‐glucose cotransporter‐2 inhibitor‐treated non‐obese type 2 diabetes: A single‐centre, randomized, crossover trial

To examine the effects of the thiazolidinedione (TZD) pioglitazone on reducing ketone bodies in non‐obese patients with T2DM treated with the sodium‐glucose cotransporter‐2 (SGLT2) inhibitor canagliflozin. Click to show full abstract

Keywords: ketone bodies; sodium glucose; non obese; glucose cotransporter

Journal Title: Diabetes
Year Published: 2024

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
0

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended